🇺🇸 FDA
Pipeline program

ES414

401

Phase 1 mab completed

Quick answer

ES414 for Prostate Cancer is a Phase 1 program (mab) at Aptevo Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aptevo Therapeutics
Indication
Prostate Cancer
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials